Northwestern Medicine is a global leader in clinical trial research, including spine CLARITY is a randomized study designed ...

Chief Strategy Officer Ryan Bond stated, "This milestone ensures we reach the study's conclusion, potentially unlocking broad ...

We recently compiled a list of the 12 AI News and Ratings You Should Not Miss. In this article, we are going to take a look ...

Aclarion stock is trading higher on Tuesday after the company announced it secured funding for its CLARITY trial of its ...

Inc trading halted, volatility trading pauseMaximize Your Portfolio with Data Driven Insights:Leverage the power of ...

Aclarion, Inc. (ACON) is up by 10 percent on Tuesday after announcing that it has secured full funding for its pivotal CLARITY trial.

Chicago-based Northwestern Medicine will be the first site for Clarion's Clarity trial for spine surgery, according to a Feb. 6 news release.

BROOMFIELD, Colo., Jan. 31, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that ...

Aclarion, Inc. is set to showcase its advanced platform, NOCISCAN, at the Selby Spine Conference, presented by Dr. Sigurd Berven. NOCISCAN combines MR Spectroscopy and augmented intelligence to ...